Cargando…

Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos

Cohesin rings interact with DNA and modulate the expression of thousands of genes. NIPBL loads cohesin onto chromosomes, and WAPL takes it off. Haploinsufficiency for NIPBL causes a developmental disorder, Cornelia de Lange syndrome (CdLS), that is modeled by Nipbl(+/−) mice. Mutations in WAPL have...

Descripción completa

Detalles Bibliográficos
Autores principales: Kean, Connor M., Tracy, Christopher J., Mitra, Apratim, Rahat, Beenish, Van Winkle, Matthew T., Gebert, Claudia M., Noeker, Jacob A., Calof, Anne L., Lander, Arthur D., Kassis, Judith A., Pfeifer, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710879/
https://www.ncbi.nlm.nih.gov/pubmed/36449618
http://dx.doi.org/10.1126/sciadv.add4136
_version_ 1784841456669687808
author Kean, Connor M.
Tracy, Christopher J.
Mitra, Apratim
Rahat, Beenish
Van Winkle, Matthew T.
Gebert, Claudia M.
Noeker, Jacob A.
Calof, Anne L.
Lander, Arthur D.
Kassis, Judith A.
Pfeifer, Karl
author_facet Kean, Connor M.
Tracy, Christopher J.
Mitra, Apratim
Rahat, Beenish
Van Winkle, Matthew T.
Gebert, Claudia M.
Noeker, Jacob A.
Calof, Anne L.
Lander, Arthur D.
Kassis, Judith A.
Pfeifer, Karl
author_sort Kean, Connor M.
collection PubMed
description Cohesin rings interact with DNA and modulate the expression of thousands of genes. NIPBL loads cohesin onto chromosomes, and WAPL takes it off. Haploinsufficiency for NIPBL causes a developmental disorder, Cornelia de Lange syndrome (CdLS), that is modeled by Nipbl(+/−) mice. Mutations in WAPL have not been shown to cause disease or gene expression changes in mammals. Here, we show dysregulation of >1000 genes in Wapl(Δ/+) embryonic mouse brain. The patterns of dysregulation are highly similar in Wapl and Nipbl heterozygotes, suggesting that Wapl mutations may also cause human disease. Since WAPL and NIPBL have opposite effects on cohesin’s association with DNA, we asked whether decreasing Wapl dosage could correct phenotypes seen in Nipbl(+/−) mice. Gene expression and embryonic growth are partially corrected, but perinatal lethality is not. Our data are consistent with the view that cohesin dynamics play a key role in regulating gene expression.
format Online
Article
Text
id pubmed-9710879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-97108792022-12-07 Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos Kean, Connor M. Tracy, Christopher J. Mitra, Apratim Rahat, Beenish Van Winkle, Matthew T. Gebert, Claudia M. Noeker, Jacob A. Calof, Anne L. Lander, Arthur D. Kassis, Judith A. Pfeifer, Karl Sci Adv Biomedicine and Life Sciences Cohesin rings interact with DNA and modulate the expression of thousands of genes. NIPBL loads cohesin onto chromosomes, and WAPL takes it off. Haploinsufficiency for NIPBL causes a developmental disorder, Cornelia de Lange syndrome (CdLS), that is modeled by Nipbl(+/−) mice. Mutations in WAPL have not been shown to cause disease or gene expression changes in mammals. Here, we show dysregulation of >1000 genes in Wapl(Δ/+) embryonic mouse brain. The patterns of dysregulation are highly similar in Wapl and Nipbl heterozygotes, suggesting that Wapl mutations may also cause human disease. Since WAPL and NIPBL have opposite effects on cohesin’s association with DNA, we asked whether decreasing Wapl dosage could correct phenotypes seen in Nipbl(+/−) mice. Gene expression and embryonic growth are partially corrected, but perinatal lethality is not. Our data are consistent with the view that cohesin dynamics play a key role in regulating gene expression. American Association for the Advancement of Science 2022-11-30 /pmc/articles/PMC9710879/ /pubmed/36449618 http://dx.doi.org/10.1126/sciadv.add4136 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Kean, Connor M.
Tracy, Christopher J.
Mitra, Apratim
Rahat, Beenish
Van Winkle, Matthew T.
Gebert, Claudia M.
Noeker, Jacob A.
Calof, Anne L.
Lander, Arthur D.
Kassis, Judith A.
Pfeifer, Karl
Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos
title Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos
title_full Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos
title_fullStr Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos
title_full_unstemmed Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos
title_short Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos
title_sort decreasing wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in nipbl(+/−) embryos
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710879/
https://www.ncbi.nlm.nih.gov/pubmed/36449618
http://dx.doi.org/10.1126/sciadv.add4136
work_keys_str_mv AT keanconnorm decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT tracychristopherj decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT mitraapratim decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT rahatbeenish decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT vanwinklematthewt decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT gebertclaudiam decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT noekerjacoba decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT calofannel decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT landerarthurd decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT kassisjuditha decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos
AT pfeiferkarl decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos